Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
NCT00090103
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
4844
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Hyperplasia
Interventions
DRUG:
dutasteride 0.5mg once daily for 4 years
DRUG:
tamsulosin 0.4mg once daily for 4 years
Sponsor
GlaxoSmithKline